DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

DarioHealth schedules Q2 2026 earnings call; no financials or guidance disclosed.

What the company is saying

DarioHealth Corp. is announcing the timing and access details for its Q2 2026 financial results release and associated conference call, scheduled for August 11th, 2026 at 8:30 a.m. Eastern Time. The announcement highlights the participation of CEO Erez Raphael, COO Lara Dodo, and CFO Chen Franco-Yehuda as hosts for the event. The company describes itself as an AI-powered healthcare technology provider, emphasizing a platform built on over 13 billion proprietary longitudinal healthcare data points collected over more than a decade. The language used in the company description is broad and aspirational, referencing improved health outcomes and cost reduction, but does not provide supporting data or specific examples. The announcement is primarily logistical, with the only forward-looking statement relating to the scheduled release date. No actual financial results, operational milestones, or new business developments are mentioned or implied.

What the data suggests

The only concrete numbers disclosed are the event timing (August 11th, 2026 at 8:30 a.m. ET), reporting period (Q2 ended June 30th, 2026), and the scale of the company's data platform (over 13 billion data points). There are no revenue, profit, cash flow, or guidance figures provided. The announcement does not include any period-over-period comparisons, financial direction, or operational KPIs. The completeness of disclosure is high for event logistics but absent for financial analysis. An independent analyst would conclude that no assessment of business performance, growth trajectory, or financial health is possible from this release. The gap between the company's broad claims about its platform and the absence of outcome or financial data is significant.

Analysis

The announcement is a standard notice of an upcoming earnings release and conference call, with no financial results, operational milestones, or forward-looking projections beyond the event date itself. The only forward-looking claim is the scheduling of the earnings release, which is a routine disclosure and not promotional. The company description contains generic statements about AI-powered healthcare and platform capabilities, but these are not paired with any measurable outcomes or financial data. There is no mention of capital outlay, acquisitions, or long-term projects. The language is factual and event-focused, with no evidence of narrative inflation or exaggerated claims. The gap between narrative and evidence is minimal, as the announcement does not attempt to frame any operational or financial progress.

Risk flags

• ●Disclosure risk is high because the announcement provides no financial data, guidance, or operational metrics, preventing investors from assessing recent performance or trends. This matters because investors cannot make informed decisions until the actual results are released.
• ●Narrative risk is present due to the use of broad, aspirational language about AI capabilities and healthcare outcomes without supporting evidence or quantifiable outcomes. This pattern can lead to misaligned expectations if not substantiated in future disclosures.
• ●Event risk is minimal, as the only forward-looking element is the scheduled earnings release. However, the absence of any early indicators or guidance means investors face a binary information event on August 11th, 2026, with no ability to anticipate results.

Bottom line

This announcement is strictly a notice of DarioHealth Corp.'s upcoming Q2 2026 earnings release and conference call, with no financial results, guidance, or operational updates disclosed. The company's description of its AI-powered healthcare platform is not supported by any outcome data or metrics in this release. Investors have no new information to assess business momentum, profitability, or risk ahead of the August 11th event. The only actionable step is to note the call date and await the actual financial disclosures. The most important takeaway is that this announcement is not actionable for investment decisions until the underlying results are published.

Announcement summary

(NASDAQ:DRIO) DarioHealth Corp. announced that it will release its financial results for the 2nd quarter ended June 30th, 2026 and will host a conference call and webcast at 8:30 a.m. Eastern Time, on Tuesday, August 11th, 2026, before the market opens. The conference call will be hosted by Erez Raphael, Chief Executive Officer, Lara Dodo, Chief Operations Officer, and Chen Franco-Yehuda, Chief Financial Officer. Participants can dial in using 1-800-717-1738 (domestic) or 1-646-307-1865 (international), or use the Call me™ link for instant access. The webcast link is https://viavid.webcasts.com/starthere.jsp?ei=1767650&tp_key=4cfb9bb10d. A replay of the call will be available approximately three hours after completion of the conference call through Tuesday, August 25th, 2026, by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and using replay passcode 1188083. DarioHealth Corp. is described as an AI-powered healthcare technology company with a platform powered by more than 13 billion proprietary longitudinal healthcare data points collected over more than a decade. The company projects the expected date of its earnings release as August 11th, 2026.

Disagree with this article?